These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 12760193)
21. Pediatric stroke initiatives and preliminary studies: What is known and what is needed? Sofronas M; Ichord RN; Fullerton HJ; Lynch JK; Massicotte MP; Willan AR; deVeber G Pediatr Neurol; 2006 Jun; 34(6):439-45. PubMed ID: 16765821 [TBL] [Abstract][Full Text] [Related]
22. Antithrombotic treatment in atrial fibrillation. Lip GY; Boos CJ Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982 [TBL] [Abstract][Full Text] [Related]
23. Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome. Paciaroni M; Agnelli G; Caso V; Venti M; Milia P; Silvestrelli G; Parnetti L; Biagini S J Thromb Haemost; 2005 Jun; 3(6):1218-23. PubMed ID: 15892862 [TBL] [Abstract][Full Text] [Related]
24. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists. Sztriha LK; Vécsei L Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389 [TBL] [Abstract][Full Text] [Related]
26. Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease? Beckman JA Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S12-6. PubMed ID: 19530155 [TBL] [Abstract][Full Text] [Related]
27. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Jiang WJ; Xu XT; Du B; Dong KH; Jin M; Wang QH; Ma N Neurology; 2007 Feb; 68(6):420-6. PubMed ID: 17283316 [TBL] [Abstract][Full Text] [Related]
28. New therapeutic strategies with antiplatelet agents. Micieli G; Cavallini A Neurol Sci; 2004 Mar; 25 Suppl 1():S13-5. PubMed ID: 15045613 [TBL] [Abstract][Full Text] [Related]
29. Alterations in treatment preferences for intracranial atherosclerotic disease following SAMMPRIS. Ding D Cerebrovasc Dis; 2014; 37(5):391. PubMed ID: 24968891 [No Abstract] [Full Text] [Related]
30. Antithrombotic strategies for atrial fibrillation: on the threshold of changes? No. Pengo V J Thromb Haemost; 2005 Mar; 3(3):433-5. PubMed ID: 15748228 [No Abstract] [Full Text] [Related]
31. Antithrombotic strategies for atrial fibrillation: on the threshold of changes? Yes. Di Pasquale G; Casella G J Thromb Haemost; 2005 Mar; 3(3):428-32. PubMed ID: 15748227 [No Abstract] [Full Text] [Related]
32. Introduction to point-counterpoint. Blackham KA J Neurointerv Surg; 2012 Mar; 4(2):82. PubMed ID: 22318261 [No Abstract] [Full Text] [Related]
33. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Chaturvedi S; Turan TN; Lynn MJ; Kasner SE; Romano J; Cotsonis G; Frankel M; Chimowitz MI; Neurology; 2007 Nov; 69(22):2063-8. PubMed ID: 18040012 [TBL] [Abstract][Full Text] [Related]
35. Thrombolytic therapy with CA-7, a fibrinolytic enzyme from Aspergillus oryzae: a report of two representative cases. Roschlau WH Can Med Assoc J; 1968 Apr; 98(16):757-61. PubMed ID: 5646112 [No Abstract] [Full Text] [Related]
36. FPIN's clinical inquiries. Aspirin in patients with acute ischemic stroke. Park MK; Smith PC; Wanserski G; Neher JO Am Fam Physician; 2009 Feb; 79(3):226-7. PubMed ID: 19202970 [No Abstract] [Full Text] [Related]
37. Vitamins and stroke: the homocysteine hypothesis still in doubt. Ntaios GC; Savopoulos CG; Chatzinikolaou AC; Kaiafa GD; Hatzitolios A Neurologist; 2008 Jan; 14(1):2-4. PubMed ID: 18195649 [TBL] [Abstract][Full Text] [Related]